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Metabolic syndrome and different obesity phenotypes  
in the elderly women population: Iran’s Health  
System on aging 
Abstract  
Background: Current literature has been focused on types of obesity with normal BMI 
(body mass index), but metabolically unhealthy.This study evaluates the prevalence of 
metabolical phenotypes of obesity. We also identified the best obesity index in predicting 
the components of metabolic syndrome (MetS). 
Methods: A cross-sectional study has been conducted on 164 women over 60 years. 
Anthropometric parameters, body fat percentage (%BF), and biologic criteria were 
measured to assess the types of obesity. Unhealthy metabolic was defined by modified 
Adult Treatment Panel III, and obesity based on BMI≥25.ANOVA and logistic regression 
were utilized for the association of MetS components and obesity phenotypes, and linear 
regression logistic for finding the best MetS related obesity index. 
Results: The prevalence of metabolically unhealthy was 45.7%, out of which 33.3% was 
among the individuals with normal BMI.Logistic regression has shown that triglyceride 
(TG) (OR=3.30, p<0.001) and high density lipoprotein (HDL-C) (OR=2.15,p<0.01) was 
independently related to metabolically healthy and normal weight(MHNW) phenotype. 
Moreover, TG (OR=3.92,p<0.001), HDL-C (OR=2.18,p<0.001), fasting blood 
glucose(FBG) (OR=1.73,p<0.01) and waist circumference(WC) (OR=3.18,p<0.001) are 
correlated significantly with metabolically unhealthy and overweight/obese (MUO) and 
also TG (OR=2.88,p<0.001) and WC (OR=2.67,p<0.001) with metabolically unhealthy 
and overweight/obese(MHO).WC followed by %body fat (BF) showed to be highly 
correlated with the prognosis of MetS components. 
Conclusions: There is a high prevalence of unhealthy metabolic among the elderly 
women,even with normal weight.There were different associations between MetS 
components and various obesity phenotypes.TG was the most powerful indicator for the 
prognosis of unhealthy metabolic phenotypes which was independently correlated with the 
WC, %BF and BMI. 
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Obesity consists of different subtypes with different metabolic profiles. Based on 
body mass index (BMI) and metabolic status, obesity is categorized into four groups which 
includes metabolically healthy and normal weight (MHNW), metabolically unhealthy and 
normal weight (MUNW), metabolically healthy and overweight/obese (MHO), 
metabolically unhealthy and overweight/obese (MUO) (1). MHNW is a subset of 
individuals with normal weight based on BMI and a high body fat content of visceral fat. 
These individuals have shown an increase in the risk of cardiovascular disease (CVD) (2). 
On the other hand, within the obese population, the small portion (10-25%) who do not 
display metabolic disturbances are termed MHO (3).  
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Different mechanisms behind the different obesity 
phenotypes include genetic, socioeconomic and behavioral 
factors, some of which may be modifiable (4). Studies also 
have shown that obesity-related metabolic phenotype 
changes over time. They found that the transition from 
menopause to aging is accompanied by changes in metabolic 
status in individuals with different obesity phenotypes (5-7). 
Elderly people in particular are faced with considerable 
changes in body composition and also redistribution fat in 
the body. Therefore, aging can put people at an increased 
risk of developing central obesity and metabolic disorders as 
a result of multiple age-related physiological mechanisms 
(8). This is because excess total body fat, specifically intra-
abdominal fat that is associated with CVD risk factors, such 
as insulin resistance, diabetes, hypertension, and 
dyslipidemia, are all components of metabolic syndrome 
(MetS) (9,10). 
Statistics are indicative of an increasing trend in the 
prevalence of obesity and MetS in Iran (5, 6, 11, 12) and 
other countries (1, 7, 9, 10, 13). Unhealthy metabolic 
prevalence among individuals with normal weight and 
overweight varies in different studies. In one study, the 
prevalence of unhealthy metabolic was reported 67% for 
elderly individuals with normal weight compared to 81% 
among overweight of the same age group (13). Studies on 
different obesity subtypes are very limited in elderly women 
in Iran. A study conducted on individuals of the age range of 
20-72 in Qazvin, Iran demonstrated the unhealthy metabolic 
phenotype prevalence as 33.8% for normal weight men, and 
39.8% for women (11).  
This is while its prevalence and correlation with various 
obesity phenotypes are still unclear. Moreover, some of the 
studies demonstrated a relation between blood pressure, 
HDL-C, and triglyceride only with a single phenotype of 
obesity (for example MHUNW or MHO) (2, 11, 13). Others 
have examined the relationship between the phenotype of 
obesity with risk of development of diabetes, CVD or cancer 
in different age groups and demographics (1, 3, 12), but the 
association between MetS and all of the obesity phenotypes 
together, especially in elderly people is less investigated. 
We believe that our understanding about the prevalence 
of various obesity phenotypes, and their correlation with 
MetS components can help us better in our decision making 
about the elderly individuals’ health.  Thus, this study 
determines the prevalence of different obesity phenotypes 
and measures association between them with MetS 
components, and finally, identifies the best index of obesity 
for predicting MetS components in elderly women in Babol, 
Iran (in 2011).      
 
 
Methods 
Subject: This cross-sectional study was conducted in the 
rural areas of the central part of Babol in Mazandaran, Iran.  
The participants were recruited through community 
advertisement by poster.  The posters were distributed in the 
rural health clinics affiliated with the Babol University of 
Medical Sciences, Iran. 306 volunteers were enrolled.  After 
the exclusion of 142 individuals in terms of exclusion 
criteria and lack of consent to participate in the study, a total 
number of 164 eligible women 60 years or over with lipid 
and/or glucose disorders, abdominal obesity or hypertension 
remained for the study. With the presumption of prevalence 
of MetS (40%), the allocated sample size could estimate the 
prevalence of MetS with confidence level of 95% and 
marginal error of 0.07. 
All the participants were free of kidney, liver, thyroid, 
cardiovascular disease, cancer or any other chronic diseases 
and that were confirmed through history and medical reports 
and documents. They also did not receive any medications 
for diabetes, hyperlipidemia and hypertension.  
 A questionnaire on demographic characteristics was 
completed by the researcher for each participant based on a 
face-to-face interview. The study protocol was approved by 
the Ethics Committee of Babol University of Medical 
Sciences (NO.:MUBABOL.REC.1388.1). All participants 
provided an informed written and signed consent form. 
Anthropometric Measurements: Participants’ height was 
measured using a stadiometer without shoes to the nearest 
0.5 cm. Weight, body fat percentage (%BF), and BMI were 
measured with composition analyzer (Omron HBF-306 body 
fat analyzer). BMI and %BF values were defined according 
to the World Health Organization criteria (1). Waist 
circumference (WC) was measured at the mid-point between 
the iliac crest and the lowest rib and hip at the widest point. 
BMI was subdivided into normal weight if BMI was less 
than 25 and overweight/obese if BMI was 25 or greater. The 
combination of overweight (25–29.9 kg/m2), and obese (≥30 
kg/m
2
) in one group overweight/obese was done to increase 
statistical power.  In addition, abnormal %BF was defined as 
%BF over the gender-specific tertile (38% for women and 
26% for men). 
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Metabolic healthy: A modified Adult Treatment Panel 
(ATP) III definition of MetS criteria was used to define 
metabolically healthy (<3 risk characteristics), including 
WC>80 cm; HDL-C <50 mg/dL; triglyceride ≥150 mg/dL; 
fasting blood glucose ≥100 mg/dL; and systolic blood 
pressure ≥130 mmHg and diastolic ≥85 mmHg. Participants 
received specific instruction prior to their blood sample 
including no food or beverage (except water) for 10-12 hours 
overnight fasting. 10 mL of venous blood was drawn (at 7-8 
am) and collected into test tubes. Serum was separated by 
centrifugation within 15 minutes of collection. The total 
cholesterol (TC) and TG levels were measured using an 
Elitech kit from France; LDL-C, HDL-C, and FBG were 
assayed on a Mindray-BS300 chemistry autoanalyzer 
(Mindray-BS300, Nanshan, Shenzhen, China). Systolic and 
diastolic blood pressures were assessed using the ALPK2 
aneroid model sphygmomanometer, (Tanaka Sangyo, Co. 
LTD. Tokyo, Japan) by the researcher, twice on the right arm 
after patients were instructed to remain seated for 10 
minutes;. The average of two seated systolic and diastolic 
blood pressure measurements were used for data analysis.  
Statistical analysis: Normality of variable of interest was 
tested by Kolmogorov–Smirnov.  The analysis compared the 
four metabolic and obesity phenotypes using ANOVA for 
normally distributed continuous variables. Tukey test served 
as a post-hoc test to perform a pairwise comparison of the 
means to see where the significant difference lies. The 
independent association of the MetS components with 
different obesity phenotypes was assessed by logistic 
regression. The MetS components were classified as normal 
or abnormal as defined by ATP III. The participants with 
normal status were considered as reference. Also, multiple 
linear regressions were used to evaluate the prediction of 
metabolic biomarkers of CVD by %BF and anthropometric 
measurements. The two-tailed p-value less than 0.05 was 
considered significant. The statistical analyses were all 
performed using SPSS for windows (Version 20).  
 
 
Results 
The study was performed on elderly women with a BMI 
26.8±0.44, mean age of 64.2±3.8 years and mean age of 
menopause 45.9±4.3 years. Among the 164 subjects, 75 
(45.7%) individuals were diagnosed with unhealthy 
metabolic which includes 25 (15.2%) MHNW and 50 
(30.5%) MUO (Table 1).  
Table 1. Physical and biochemical characteristics in the elderly women (mean ± SD) 
 Overall 
 n=164 
MHNW 
(n=43) 
MUNW 
(n=25) 
MHO 
(n=46) 
MUO 
(n=50) 
BMI (kg/m
2
) 26.8±0.44 24.2±0.54 24.8±0.59 28.4±0.68
a 
29.8±0.81
a 
WC (cm) 90.75±6.8 81.2±3.2 83.6±5.4 96.8±8.5
a
 101.4±9.5
a 
Body fat (%) 40.3±1.48 32.3±0.62 39.2±0.67
b 
40.4±0.96
b 
44.8±1.96
b 
SBP (mmHg) 137±0.78 134±0.36 135±0.44 131±0.47 139±0.56 
DBP (mmHg) 73±1.3 73±0.90 71±1.34 74±1.4 76±1.38 
TC (mg/dL) 205.6±34 213.2±30 231.6±23 217.8±26
 
226.2±25
 
LDL-C (mg/dL) 121±30 125±28 138±20 127±23 142±24 
HDL-C (mg/dL) 51±4.5 64±5.48 49±3.6
 c
 59±5.2 44±4.01
 c
 
TG (mg/dL) 177±21 150±32 196±21
 c
 164±29
d 
212±26
 c
 
FBG (mg/dL) 97.8±2.2 93±2.18 102.8±2.01
 c
 95±2.34 104.5±2.49
 c
 
TG/HDL-C ratio 3.38±0.27 2.56±0.34 4±0.25
c 
2.42±0.21 4.90±0.28
c 
MHNW: metabolically healthy and normal weight; MUNW: metabolically unhealthy and normal weight; MHO: metabolically healthy and overweight/obese; 
MUO: metabolically unhealthy and overweight/obese; BMI: body mass index; WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood 
pressure; TC: total cholesterol; LDL-C: low density lipoprotein; HDL-C: high density lipoprotein; TG: triglyceride; FBG: fasting blood glucose  
a. p˂0.001 versus other groups          b. p˂0.001 versus MHNW group          c. p˂0.001 versus other groups       d. p˂0.01 versus MHNW group 
 
The most common components of MetS were higher WC 
(in more than half of the individuals), followed by low HDL-
C and high TG levels (in more than 40% of the individuals).  
 
There was no meaningful difference among the 4 metabolic  
cluster groups in terms of demographics and medical history.   
Post-hoc test depicted substantially higher TG, FBG, 
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TG/HDL-C levels, and lower levels of HDL-C among 
unhealthy metabolic groups compared to the other groups. 
WC displayed no significant difference between the two 
groups of MUNW and MHNW (Table 1), in contrast to %BF 
(p<0.0001). Evaluation of the independent effect of each 
MetS component on different obesity phenotypes compared 
to the MHNW group (as reference group) showed that TG 
(OR=3.30, p<0.001) and HDL-C (OR=2.15, p<0.01) were 
independently related to MUNW phenotype. Moreover, TG 
(OR=3.92, p<0.001), HDL-C (OR=2.18, p<0.001), FBG 
(OR=1.73, p<0.01) and WC (OR=3.18, p<0.001) are 
correlated with MUO and also TG (OR= 2.88, p<0.001) and 
WC (OR= 2.67, p<0.001) with MHO (Table 2). 
The relationship between indexes of obesity and MetS 
components revealed that WC was an independent predictor 
for TG, FBG, HDL-C and TG/HDL-C, respectively. In the 
same way, %BF was an independent predictor for TG, FBG, 
as well as BMI for TG (Table 3). 
 
Table 2. Multiple Logistic regression analysis of the MetS components and different phenotypes of obesity 
 
Predictor variables MUNW MHO MUO 
Unadjusted 
OR (95% CI) 
Adjusted 
OR (95% CI) 
Unadjusted 
OR (95% CI) 
Adjusted 
OR (95% CI) 
Unadjusted 
OR (95% CI) 
Adjusted 
OR (95% CI) 
WCa 1.94 (0.71-3.15) 1.86 (0.55-4.24) 3.15 (1.98-3.65)1 2.67 (2.13-4.67)1 3.25 (2.01-5.42)1 3.18 (2.11-4.32)1 
TGb 3.37 (1.46-5.28)1 3.30 (2.67-5.45)1 2.91 (1.49-4.33)2 2.88 (2.12-3.65)1 3.88 (2.68-6.87)1 3.92 (2.28-5.17)1 
SBPc 1.80 (0.94-2.32) 2.34 (0.98-4.34) 1.32 (0.66-3.18) 1.58 (0.60-2.23) 1.14 (0.39-3.62) 0.87 (0.25-3.44) 
DBPd 0.46 (0.35-1.40) 1.22 (0.45-2.56) 0.26 (0.63-2.82) 1.06 (0.43-2.29) 0.82 (0.47-3.42) 0.76 (0.57-2.88) 
HDL-Ce 1.36 (1.00-2.12)2 2.15 (1.29-3.19)2 1.02 (0.45-2.36) 0.92 (0.85-2.71) 1.68 (1.08-2.98)2 2.18 (1.98-3.72)1 
FBGf 1.92 (1.36-4.44)2 1.14 (0.51-3.89) 0.80 (0.22-4.40) 1.49 (0.72-3.98) 1.14 (1.08-4.85)2 1.73 (1.26-4.65)2 
Note.WC, waist circumference; TG, triglyceride; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high density lipoprotein; FBG, fasting blood 
glucose; MUNW, metabolically unhealthy and normal weight;  MHO, metabolically healthy and overweight/obese;  MUO, metabolically unhealthy and overweight/obese. 
Components of the MetS were defined as abnormal vs. normal.  Moreover, different phenotypes of obesity were compared with MHNW. 
a waist circumference˃80cm          b TGs ≥150 mg/dL         c HDL-C <50 mg/dL         d Systolic blood pressure ≥130 mmHg 
 eDiastolic blood pressure ≥85 mmHg       f fasting blood glucose ≥100 mg/dL    1. P value˂0.001    2. P value <0.01 
 
Table 3.   Multiple linear regression coefficient of %BF, WC and BMI (independent variables) with metabolic syndrome 
components (dependent variables) 
Dependent 
Variables 
%BF WC BMI 
 Unstandardize
d coefficients 
B (SE) 
Standardized 
coefficients 
β 
Unstandardized 
coefficients 
B (SE) 
Standardized 
coefficients 
β 
Unstandardized 
coefficients 
B (SE) 
Standardized 
coefficients 
β 
TC(mg/dL) 0.391 (0.12) 0.079 0.283 (0.016) 0.13 0.150 (0.450) 0.080 
LDL-C(mg/dL) 0.016 (0.026) 0.064 0.022 (0.072) 0.06 0.06 (0.552) 0.017 
HDL-C 
(mg/dL) 
-0.293 (0.37) -0.156 -0.430 (0.004) -0.292 -0.034 (0.251) -0.135 
TG (mg/dL) 0.634 (0.06) 0.3341 0.570 (0.092) 0.551 0.159 (0.084) 0.242 
FBG (mg/dL) 0.231 (0.07) 0.2012 0.37 (0.0.87) 0.341 0.056 (0.622) 0.120 
TG/HDL-C  0.084 (0.29) 0.012 0.064 (0.004) 0.232 0.014 (0.363) 0.073 
SBP (mm/Hg) 0.003 (0.038) 0.026 0.002 (0.003) 0.026 0.064 (0.165) 0.105 
DBP(mm/Hg) 0.005 (0.014) 0.029 0.001  (0.005) 0.052 0.04 (0.065) 0.021 
Note.TC, total cholesterol; LDL-C, low density lipoprotein; HDL-C, high density lipoprotein; TG, triglyceride; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; BF, body fat percentage; WC, waist circumference; BMI, body mass index. 
1. P value˂0.001     2. P value <0.01
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Discussion 
The study revealed that the prevalence of unhealthy 
metabolic was 45.7% in elderly women, with 36.8% among 
individuals with normal weight compared to 52.1% among 
overweight individuals. Roberson et al. (2014) also reported 
the prevalence of unhealthy metabolic as 67% for elderly 
individuals (80 years and older) with normal weight 
compared to 81% among overweight of the same age group, 
with marginal difference of 14% (13), which was similar to 
the findings of the present study (i.e., 36.8% versus 52.1%, 
with 15.3% difference). Unhealthy metabolic prevalence 
among elderly individuals with normal weight and 
overweight varies in different studies. For example, in one 
study, it has a prevalence rate of 22% among overweight, 
and 56% in normal weight individuals (14).  
There are no studies about MUNW of elderly women in 
Iran. A study in Iran, Ghazvin, conducted on individuals 
with age range of 20-72 demonstrated the unhealthy 
metabolic phenotype prevalence as 33.8% for normal weight 
men, and 39.8% for women. In this study, the lower limit of 
top quintile of HOMA-IR values was considered the 
unhealthy metabolic diagnostic criteria (11).  
These differences might partially be due to ethnicity 
variations causing metabolic disorders and different obesity 
phenotypes. Furthermore, definition of obesity based on 
BMI or excess body fat might be another factor also causing 
the differences (15). On the other hand, there is no general 
agreement in terms of excess adiposity. Researches 
introduced various cut-off points for defining the %BF 
among the elderly population (35-38% in women, and 24-
26% in men) (1, 16, 17). Moreover, various studies utilized 
varying criteria for diagnosing the unhealthy metabolic; 
some of HOMA-IR amounts within the highest quartile ratio 
or more than 1.69 (18), some others use the ATP III criteria 
for Mets terminology (12). Recently, Lee et al. (2015) have 
utilized the TYG indicator (triglyceride x FBG) for MUNW 
identification (19). At anyrate, more studies are required to 
determine the obesity phenotypes in elderly population of 
Iran.  
We found that the amounts of TG, HDL-C, TG/HDL-C, 
and FBC have meaningful differences among unhealthy 
metabolic groups when compared to other groups. Previous 
studies also reported a higher prevalence of MetS and its 
components with the increase of %BF among normal weight 
individuals (2-3) as well as individuals with overweight/ 
obesity (14, 16). Tsou study (2012) on MetS prevalence 
among the elderly population of Taiwan with MUNW 
phenotype, also demonstrated a relatively high MetS 
prevalence in both groups of normal weight and 
overweight/obese (20). Conducted studies in Iran also 
depicted an increasing trend (4 times higher) of MetS 
prevalence among Tehran adults with normal weight (21, 
22). As a CVD risk factor, MUNW is linked to adiposity 
concept. This is further discussed in a way that in MUNW, 
lean mass decreases and the fat mass rises while the BMI is 
within the normal range. This situation introduces the 
concept of sarcopenic obesity among the elderly population 
(3). Therefore, metabolic disorders with MUNW, like MetS, 
are associated with more complications in the elderly 
individuals (23). Jeans et al. (2014) demonstrated that 
sarcopenic obesity is clearly accompanied by the increased 
risk of MetS among the elderly individuals compared to 
individuals without sarcopenic obesity (3). In clinical 
settings, these individuals are not usually regarded as the 
cases with obesity or higher CVD risk, and therefore, are 
missed.  
Individuals with MHO are the counterpoints of these 
individuals. Recent studies have shown that these individuals 
are known as obese with high BMI, and huge subcutaneous 
fat storage in legs, hips, and buttock areas. These individuals 
have lower risk of CVD. Two longitudinal studies in Tehran, 
Iran showed that individuals with normal weight but 
dysmetabolic status are at greater risk for CVD than the 
healthy obese individuals (5, 22). However, some studies 
showed an increased CVD risk in MHO, when compared to 
the individuals with normal BMI and %BF (24, 25). The 
current research results demonstrated that WC and TG were 
independent risk factors for MHO groups when compared to 
the MHNW group. A recent longitudinal study (2015) of 
2368 people in America has indicated that MHO might be an 
unstable status, and throughout time, might develop into 
multiple metabolic abnormalities (26).  
In the present study, when we evaluated the independent 
effects of Mets components on different obesity phenotypes 
we found that TG is the strongest independent predictors of 
unhealthy metabolic phenotypes after WC and HDL-C. High 
level of TG has been reported among individuals with high 
risk of CVD (11, 12) but its correlation with various obesity 
phenotypes especially among elderly population has not 
been studied very thoroughly. Hashemipour et al. (2015) 
demonstrated that among the different Mets components, TG 
was the only component which is solely related to insulin 
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resistance in women with MUNW (11). 
Hypertriglyceridemia is the key feature of the MetS, and is 
linked with CVD. Elevated serum TG in older women may 
be considered as an indicator of enhanced TG-rich VLDL-C, 
which is particularly atherogenic. Additionally, elevated TG 
among women has been shown to generate greater 
atherogenic significance than that of men. In obese women 
with excess deep abdominal fat and also in women with 
increased %BF without overweight could be responsible for 
the reduction in plasma HDL-C levels (27). Lee et al. (2014) 
have recently introduced TG measurement along with FBG 
(TYG indicator) as useful indicator in MUNW definition 
(19). In the current study, WC, followed by %BF, depicted 
the highest correlation for prediction of the presence of MetS 
components among the elderly women.  This is consistent 
with Charipour’s findings (2014) in the elderly men 
population of Isfahan, Iran (28).  
They found the WC as the best obesity indicator for the 
diagnosis of MetS in this group. Their previous study (2013), 
about finding the best indicator for MetS diagnosis 
regardless of age and sex also showed similar results (29). 
Many past studies also indicated WC and WHR as the most 
powerful instruments of Mets prognosis (30-32). Seo et al. 
(2009) also demonstrated WC at a competing level with 
visceral fat abdomen as powerful indicator for identifying 
elderly individuals at risk of MetS (33). Some researchers 
suggest that the WC, WHR and BMI are all equally useful 
indicators for the identification of metabolic abnormalities 
(34, 35). At any rate, the best obesity index for predicting 
CVD risk differs in various populations (36).  
Our study has some limitations. First, this is a cross-
sectional study which does not provide proof for a temporal 
relationship. Besides, we took BMI>25 as the obesity index 
among elderly individuals; this cutoff value may not be 
suitable for elderly individuals. Moreover, further studies are 
required to determine the BMI- cutoff value for obesity 
definition in Iranian elderly women.  Furthermore, this study 
may not cover the entire population of elderly women in the 
studied villages, thus disrupting the generalization of the 
results. However, it should be noted that given the limited 
number of women over the age of 60 in the studied areas and 
the good coverage of the population by health care providers, 
it can confidently be found that, except for women with 
health problems, the rest of the subjects entered the study. 
The strong points of the current study included 
participants` relative importance of homogeneity with 
respect to age, sex, lifestyles and health condition and that no 
one was under the treatment of glycemic, lipid-lowering or 
antihypertensive drugs; this makes the results reliable.  
In conclusion there were different associations between 
MetS components and various obesity phenotypes. The most 
unfavorable metabolic profile was related to MUO followed 
by MUNW. MHO group although metabolically healthy, 
showed a significant difference in some MetS criteria when 
compared to MHNW. This supports the previous studies 
findings in terms of possible increased risk of metabolic 
disorders in the future among this group. Due to the existing 
inconsistencies, further studies are required in this respect, 
anyway. Likewise, TG was introduced as the most powerful 
indicator for prognosis of unhealthy metabolic phenotypes 
which was independently correlated with the WC, %BF and 
BMI. Hence, enough attention must be given to MetS and 
resulting complications in elderly women with elevated 
triglyceride levels and even among normal weight 
individuals.    
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